Literatura
Kontakt Forum RSS
Ginekologija
Brojni znanstvenici istražuju uzroke, a drugi nastoje pronaći brzu i učinkovitu pomoć za liječenje ginekoloških oboljenja. Većina njih usmjerena je na tjelesne smetnje, dok je manje učinjeno na razjašnjenju psiholoških mehanizama povezanih s ovim tegobama.

Literatura

Vezano
Datum zadnje izmjene: 6. siječnja 2017.

Bosch FX, Lorincz A, Munoz N et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-65

Franco EL, Villa LL, Sobrinho JP et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999; 180: 1415-23

Bekkers RL, Massuger LF et al. Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer. Rev Med Virol 2004; 14 (29: 95-105

Muno N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New Engl J Med 2003; 394: 518-27

Antoni MH, Goodkin K. Host Moderator Variables in the Promotion of Cervical Neoplasia: I. Personality Facets. J Psychos Research 1988 (3): 327-8

de Vet HC, Sturmans F. Risk factors for cervical dysplasia: implications for prevention. Public Health; 1994; 108 (4): 241-9

de Vet HC, Knipschild PG Sturmans F. The role of sexual factors in the aetiology of cervical dysplasia. Int J Epidemiol 1993; 22 (5): 798-803

Goodkin K et al.
Stress and Hopelessness in the Promotion of Cervical Intraneoplasia to Invasive Squamous Cell Carcinoma of the Cervix. J Psychos Research 1986 (30) 1: 67-76

Glase R, Rice J, Sheridan J et al. Stress-related immune suppression: health implications. Brain Behav Immun 1987; 1(1):7-20

Moyad MA, Pienta KJ. Mind-body effect: insulinlike growth factor-1; clinical depression; and breast, prostate and other cancer risk – an unmeasured and masked mediator of potential significance? Urology 2002; 59 (4 Suppl 1):4-8

Trevethan E, Layde P, Webster LA et al. Cigarette smoking and dysplasia and carcinoma in situ of the uterine cervix. JAMA 1983; 250 (4): 499-502

Lyon JL, Gardner JW, West DW et al. Smoking and carcinoma in situ of the uterine cervix. Am J Public Health 1983; 73 (5): 558-62

Moore TO, Moore AY, Carrasco D et al. Human papilloma virus, smoking and cancer. J Cutan med Surg; 2001; 5 (4): 323-8

Parazzini F, la Vecchia C, Negri E, Maggi R.Oral contraceptive use and invasive cervical cancer. Int J Epidemiol 1990; 19 (2): 259-63

Brinton LA, Reeves WC, Brenes MM et al. Oral contraceptive use and risk of invasive cervical cancer. Int J Epidemiol 1990; 19 (1): 4-11

Coker AL, McCann MF, Hulka BS, Walton LA. Oral contraceptive use and cervical intraepithelial neoplasia. J Clin Epidemiol 1992; 45 (10): 1111-8

Moreno V, Bosch FX, Munoz N, Meijer CJ, Shah KV, Walboomers JM et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 2002; 359: 1085-92

Liu T, Soong Sk, Alvarez RD, Butterworth CE Jr. A longitudinal analysis of human papillomavirus 16 infection, nutritional status, and cervical progression. Cancer Eidemiol Biomarkers Prev 1995; 4 (4): 373-80

Ho GY, Palan PR, Basu J, Romney SL, Kadish AS, Mikhail M, Wassertheil-Smoler S, Runowicz C, Burk RD. Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. Int J Cancer 1998; 78 (5): 594-9

Giuiliano AR, Papenfuss M, Nour M et al. Antioxidant nutrients: associations with persistent human papillomavirus infection. cancer Epidemiol Biomarkers Prev 1997; 6 (11): 917-23

Kwasniewska A, Charzewska J, Tukendorf A, Semczuk M.
Dietary factors in women with dysplasia colli uteri associated with human papillomavirus infection. Nutr Cancer 1998; 30 (1): 39-45

Garcia-Closasa R, Castellsague X, Bosch X, Gonzalez CA.
The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence. Int J Cancer 2005; 117 (4): 629-37

Potischman N, Brinton LA. Nutrition and cervical neoplasia. Cancer Causes Control 1996; 7 (1): 113-26

Lee GJ, Chung HW, Lee KH, Ahn HS.
Antioxidant vitamins and lipid peroxidation in patients with cervical intraepithelial neoplasia. J Korean Med Sci 2005; 20 (2): 267-72

Sedjo RL, Papenfuss MR, Craft NE, Guiliano AR. Effect of plasma micronutrients on clearance of oncogenic human papillomavirus (HPV) infection (United States). Cancer Causes Control 2003; 14 (4):319-26

Kwasniewska A, Tukendorf A, Semczuk M.
Content of beta-carotene in blood serum of human papillomavirus infected women with cervical dysplasias. Arch Immunol Ther Exp. 1996; 44 (5-6): 309-13

Singh VN, Gaby SK. Premalignant lesions: role of antioxidant vitamins and beta-carotene in risk reduction and prevention of malignant transformation. Am J Clin Nutr 1991; 53 (1 Suppl): 386S-390S

VanEenwyk J, Davis FG, Bowen PE. Dietary and serum carotenoids and cervical intraepithelial neoplasia. Int J Cancer 1991; 48 (1): 34-8

Schiff MA, Patterson RE, Baumgartner RN, Masuk M, Asselt-King L, Wheeler CM, Becker TM. Serum Carotenoids and Risk of Cervical Intraepithelial Neoplasia in Southwestern American Indian Women. Cancer Epidemiol Biomarkers Prev 2001; 10:1219-22

Sedjo RL, Roe FJ, Abrahamsen M, Harris RB, Craft N, Baldwin S, Giuliano AR. Vitamin A, Carotenoids, and Risk of Persistent Oncogenih Human Papillomavirus Infection. Cancer Epidemiol Biomark& Prev 2002; 11: 876-84

Palan P et al. Plasma levels of beta cerotene, lycopene, canthaxantin, retinol and alpha- and gamma tocopherol in cervical intraepithelial neoplasa and cancer. Clinical Cancer Research 1996; 2:181-5

Kantesky PA, Gammon MD, Mandelbaltt J et al. Dietary intake and blood levels of lycopene: association with cervical dysplasia among non-Hispanic, black women. Nutr Cancer 1998; 31 (1): 31-40

Ribaya-Mercado JD, Blumberg JB. Lutein and Zeaxanthin and Their Potential Roles in Disease Prevention. J American Coll Nutr 2004; 23:567S-87S

Giuliano AR, Siegel EM, Roe DJ, Ferreira S, Baggio ML et al. Dietary intake and risk of persistant human papillomavirus (HPV) infection: the Ludwig-McGill HPV Natural History Study. J Infect Dis 2003; 188 (10): 1508-16

Romney SL, Duttagupta C; Basu J et al. Plasma vitamin C and uterine cervical dysplasia. Am J Obstet Gynecol 1985; 151 (7): 976-80

Slattery ML, Abbott TM, Overall JC et al. Dietary vitamins A, C and E and selenium as risk factors for cervical cancer. Epidemiology 1990; 1 (1): 8-15

Bell MC, Crowley-Nowick P, Bradlow HL et al.
Placebo-controlled trial of indole-3-carbinole in the treatment of CIN. Gynecol Oncol 2000; 78: 123-9

Jin L, Qi M, Chen DZ et al. Indole-3-carbinole prevents cervical cancer in human papilloma virus type 16 (HPV16) transgenic mice. Cancer Re 1999; 59 (16): 3991-7

Zeligs M. Diet and estrogen status: the cruciferous connection. J Med Food 1998; 1 (2): 67-81

Butterworth Jr CE; Hatch KD, Macaluso M et al. Folate deficiency and cervical dysplasia. J Am Medical Association 1992; 267 (4): 528-33

Butterworth Jr CE, Hatch KD, Soong SJ et al. Oral folic acid supplementation for cervical dysplasia: A clinical intervention trial. Am J Obstet Gynecol 1992; 166 (3): 803-9

Zarcone R, Bellini P, Carfora E et al. Folic acid and cervical dysplasia. Minerva Ginecologica 1996; 48 (10): 397-400

Ni Y, Turner D, Yates KM, Tizard I. Isolation and characterization of structural components of Aloe vera L. leaf pulp. Int Immunopharmacol. 2004;4(14):1745-55

Yagi A, Takeo S. Anti-inflammatory constituents, aloesin and aloemannan in Aloe species and effects of tanshinon VI in Salvia miltiorrhiza on heart. Yakugaku Zasshi. 2003 Jul;123(7):517-32

Ramamoorthy L, Tizard IR. Induction of apoptosis in a macrophage cell line RAW 264.7 by acemannan, a beta-(1,4)-acetylated mannan. Mol Pharmacol. 1998;53(3):415-21

European Commision Health&Consumer Protection Direcorate General. Opinion of the Scientific Committee on Food on Tahitian Noni juice. http://europa.eu.int/comm/food/fs/sc/scf/index_en.html

Palu Ak, Jensen CJ, Zhou BN, Su C. Morinda citrifolia L. (Noni): A dual inhibitor of COC-2/5-LOX Enzymes. 2005 IFT Annual Meeting July 15-20 – New Orleans, Lousiana. Session 18E, Nutraceutical & Functional Fools: General I.

Desmond D. Wong KW. Are immune responses pivotal to cancer patinet’s long term survival? Two clinical case-study reports on the effects of Morinda citrifolia (Noni). Hawaii Med J Vol 63: 182-84

Hornick CA, Myers A, Sadowska-Krowicka H et al. Inhibition of angiogenic inititation and disruption of newly established human vascular networks by juicy from Morinda citrifolia (noni). Angiogenesis, Vol 6 (2): 143-49

Wand MA, West BJ, Jensen CJ et al. Morinda citrifolia (noni): A Literature Rewiev and Recent Advances in Noni Research. Acta pharmacol sinica 23 (12): 1127-41

Gerson S. Preliminary Evaluation of the Antifungal Activity of Extracts of Morinda citrifolia Linn. American Society of Microbiology 2002, Annual Meeting May 2002; Salt Lake City, Ut.

Wang MY.
Cancer Preventive Effect of Tahitian Noni Juice at the Inititaion Stage of Carcinogenesis. 8th Biennial Symposium on Minorities, The Medicaylly Underserved & Cancer, Poster Session, Feb 6-10, 2002.

Ahn WS, Yoo J, Huh SW et al. Protective effects of green tea extracts (polyphenon E i EGCG) on human cervical lesions. Eur J Cancer Prev 2003; 12 (5): 383-90

University of Maryland Medical Center. Green Tea. http://www.unm.edu/altmed/ConsHerbs/GreenTeach.html

Iljazovic E, Ljuca D, Sahimpasic A, Avdic S. Efficacy in treatment of cervical hrhpv infection by combination of Beta interferon, and herbal therapy in woman with different cervical lesions. Bosn J Basic Med Sci. 2006;6(4):79-84

Treben M. Zdravlje iz Božje ljekarne. Mozaik knjiga Zagreb 2004

Theiss P, Kalođera Z. Ljekovito bilje za zdravu obitelj. Natur Produkt Zagreb 2004

Kuštrak D. Farmakognozija i fitofarmacija. Golden Marketing – Tehnička knjiga. Zagreb 2005

Svjetska zdravstvena organizacija. http://www.fao.org/es/ESN/Probio/probio.htm

Schneeweiß B. Darmflora und Probiotika. Ernährung&Medizin 2003; 18: 145-49

McNicol PJ, Paraskevas M, Guijon FB. The effect of vaginal microbes on in vivo and in vitro expression of human papillomavirus 16 E6-E7 genes. Cancer Detect Prev. 1999;23(1):13-21

Voravuthikunchai SP, Bilasoi S, Supamala O. Antagonistic activity against pathogenic bacteria by human vaginal lactobacilli. Anaerobe. 2006;12(5-6):221-6.

Zarate G, Nader-Macias ME. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells. Lett Appl Microbiol. 2006;43(2):174-80.

Ronnqvist PD, Forsgren-Brusk UB, Grahn-Hakansson EE. Lactobacilli in the female genital tract in relation to other genital microbes and vaginal pH. Acta Obstet Gynecol Scand. 2006;85(6):726-35

Literatura